z-logo
open-access-imgOpen Access
Modified Intermediate-Dose Cytarabine Combined with Daunorubicin Induction and Re-Induction Protocol Use in Patients with Acute Myeloid Leukemia
Author(s) -
Mozaffar Aznab,
Omid Beiki
Publication year - 2017
Publication title -
international journal of cancer management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.251
H-Index - 19
eISSN - 2538-4422
pISSN - 2538-497X
DOI - 10.5812/ijcm.7000
Subject(s) - cytarabine , medicine , daunorubicin , myeloid leukemia , transplantation , induction chemotherapy , leukemia , surgery , chemotherapy , gastroenterology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom